Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 4:35 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 524444 | NSE: EVEXIA

Evexia Lifecare Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹0.47Fairly Valued by 7.84%vs CMP ₹0.51

P/E (59.8) × ROE (0.3%) × BV (₹3.02) × DY (2.00%)

₹1.16Undervalued by 127.45%vs CMP ₹0.51
MoS: +56% (Strong)Confidence: 44/100 (Low)Models: 3 Under, 1 Fair
ModelCategoryValueWeightSignal
PE-ROEEarnings₹0.4753%Fair (-7.8%)
Net Asset ValueAssets₹3.0217%Under (+492.2%)
ROCE CapitalReturns₹1.6817%Under (+229.4%)
Revenue MultipleRevenue₹0.8813%Under (+72.5%)
Consensus (4 models)₹1.16100%Undervalued
Key Drivers: ROE 0.3% is below cost of equity. | Wide model spread (₹0–₹3) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -0.2%

*Investments are subject to market risks

Investment Snapshot

49
Evexia Lifecare Ltd scores 49/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health54/100 · Moderate
ROCE 0.3% WeakROE 0.3% WeakD/E 0.10 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money60/100 · Moderate
FII holding up 0.31% (6mo) Slight increasePromoter holding at 3.5% Stable
Earnings Quality50/100 · Moderate
OPM stable around 4% Steady
Quarterly Momentum40/100 · Moderate
Revenue (4Q): 2% YoY FlatProfit (4Q): -60% YoY Declining
Industry Rank45/100 · Moderate
P/E 59.8 vs industry 263.2 Cheaper than peersROCE 0.3% vs industry 14.3% Below peersROE 0.3% vs industry 12.9% Below peers3Y sales CAGR: 14% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:35 am

Market Cap 95.7 Cr.
Current Price 0.51
Intrinsic Value₹1.16
High / Low 2.99/0.51
Stock P/E59.8
Book Value 3.02
Dividend Yield0.00 %
ROCE0.30 %
ROE0.32 %
Face Value 1.00
PEG Ratio-300.79

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Evexia Lifecare Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Evexia Lifecare Ltd 95.7 Cr. 0.51 2.99/0.5159.8 3.020.00 %0.30 %0.32 % 1.00
Marico Ltd 96,647 Cr. 744 814/64056.4 31.21.41 %45.2 %41.3 % 1.00
Ashiana Agro Industries Ltd 3.23 Cr. 7.02 15.6/6.9664.6 5.630.00 %4.31 %3.53 % 10.0
Gujarat Ambuja Exports Ltd 6,392 Cr. 139 149/10131.1 67.50.18 %11.5 %8.64 % 1.00
Adani Wilmar Ltd 23,736 Cr. 183 291/17124.8 76.20.00 %20.9 %13.9 % 1.00
Industry Average11,412.83 Cr130.95263.2137.260.19%14.31%12.90%4.29

All Competitor Stocks of Evexia Lifecare Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 18.5724.7814.0210.656.7524.7221.2326.7121.7023.6122.0925.7325.24
Expenses 18.0224.9213.8312.016.7621.6620.9325.6221.5322.2921.0125.6324.99
Operating Profit 0.55-0.140.19-1.36-0.013.060.301.090.171.321.080.100.25
OPM % 2.96%-0.56%1.36%-12.77%-0.15%12.38%1.41%4.08%0.78%5.59%4.89%0.39%0.99%
Other Income 0.860.180.20-0.20-0.000.860.13-0.000.10-0.00-0.000.430.26
Interest -0.140.52-0.000.01-0.010.49-0.000.05-0.000.410.01-0.00-0.00
Depreciation 0.100.100.100.100.070.150.100.110.110.460.210.030.12
Profit before tax 1.45-0.580.29-1.67-0.073.280.330.930.160.450.860.500.39
Tax % 26.21%41.38%27.59%-0.00%-28.57%16.77%24.24%-0.00%25.00%31.11%25.58%28.00%25.64%
Net Profit 1.07-0.830.22-1.67-0.052.730.240.940.120.310.630.370.29
EPS in Rs 0.02-0.010.00-0.03-0.000.040.000.010.000.000.000.000.00

Last Updated: March 3, 2026, 9:58 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 5:05 am

MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 0.6233.96177.5374.10105.42100.20106.6375.5169.5556.27110.4896.67
Expenses 0.6734.07176.2674.45106.31106.51178.8173.1068.9754.31106.4093.92
Operating Profit -0.05-0.111.27-0.35-0.89-6.31-72.182.410.581.964.082.75
OPM % -8.06%-0.32%0.72%-0.47%-0.84%-6.30%-67.69%3.19%0.83%3.48%3.69%2.84%
Other Income 0.430.510.161.273.4811.7274.350.071.880.880.140.69
Interest 0.020.050.020.020.020.210.010.100.540.491.090.42
Depreciation 0.200.080.080.180.320.310.240.210.390.421.700.82
Profit before tax 0.160.271.330.722.254.891.922.171.531.931.432.20
Tax % 31.25%40.74%32.33%33.33%30.22%29.24%33.33%60.37%56.21%28.50%35.66%
Net Profit 0.110.160.900.481.573.471.280.860.671.380.931.60
EPS in Rs 0.000.000.010.010.030.060.020.010.010.020.000.00
Dividend Payout % 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)45.45%462.50%-46.67%227.08%121.02%-63.11%-32.81%-22.09%105.97%-32.61%
Change in YoY Net Profit Growth (%)0.00%417.05%-509.17%273.75%-106.06%-184.13%30.30%10.72%128.06%-138.58%

Evexia Lifecare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:68%
5 Years:2%
3 Years:14%
TTM:49%
Compounded Profit Growth
10 Years:24%
5 Years:-23%
3 Years:3%
TTM:40%
Stock Price CAGR
10 Years:14%
5 Years:-32%
3 Years:6%
1 Year:-36%
Return on Equity
10 Years:1%
5 Years:1%
3 Years:1%
Last Year:0%

Last Updated: September 5, 2025, 3:26 pm

Balance Sheet

Last Updated: March 3, 2026, 2:56 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 46.4661.9361.9361.9361.9361.9361.9361.9366.4470.80187.73187.73
Reserves 19.293.423.8411.3312.9116.4117.6718.5224.0558.59271.65378.91
Borrowings 4.6610.786.016.224.127.126.785.79704.85686.16385.771,221.60
Other Liabilities 3.5935.47147.02128.46145.51138.5855.7940.8352.1667.4575.2264.95
Total Liabilities 74.00111.60218.80207.94224.47224.04142.17127.07847.50883.00920.371,853.19
Fixed Assets 2.402.282.308.908.628.948.848.9610.9810.7249.8613.99
CWIP 0.020.200.20-0.00-0.00-0.00-0.002.160.030.030.031.18
Investments 3.550.510.520.010.010.010.870.87704.36723.79716.60878.84
Other Assets 68.03108.61215.78199.03215.84215.09132.46115.08132.13148.46153.88959.18
Total Assets 74.00111.60218.80207.94224.47224.04142.17127.07847.50883.00920.371,853.19

Reserves and Borrowings Chart

Cash Flow

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 4.1010.85-116.14-11.75-0.26-2.581.71-5.74-3.1517.02-2.26
Cash from Investing Activity + 0.222.330.55-5.920.020.54-2.437.72-696.62-17.31-17.95
Cash from Financing Activity + -3.64-12.28113.1917.630.421.590.77-0.95698.700.5620.08
Net Cash Flow 0.680.91-2.39-0.030.17-0.460.051.03-1.070.28-0.13
Free Cash Flow 4.3410.71-116.24-18.34-0.30-3.201.52-8.23-5.6016.76-1.99
CFO/OP -8,200%-9,864%-9,145%3,357%-44%52%-3%-152%-184%910%-76%

Free Cash Flow

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-4.71-10.89-4.74-6.57-5.01-13.43-78.96-3.38-704.27-684.20-381.69

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 983.15237.10286.42173.58197.42248.76156.3773.28164.47282.43306.95
Inventory Days 197.304.701.643.032.982.2711.706.9611.188.0011.30
Days Payable 187.43383.9173.2967.30158.16171.51114.48124.30186.39194.93261.26
Cash Conversion Cycle 993.01-142.11214.77109.3142.2379.5253.58-44.05-10.7495.4956.99
Working Capital Days -1,577.74248.17250.48277.72133.78244.83192.00175.23207.30343.08111.73
ROCE %0.44%1.83%0.98%2.86%6.20%2.30%2.63%0.47%0.30%0.30%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 9.87%9.87%9.87%9.87%9.26%6.29%5.87%3.49%3.49%3.49%3.36%3.49%
FIIs 6.79%3.36%3.36%1.43%0.00%1.03%1.49%0.16%0.16%0.00%0.47%0.47%
DIIs 0.28%0.28%0.28%0.28%0.27%0.17%0.17%0.09%0.09%0.09%0.09%0.09%
Public 83.08%86.49%86.48%88.42%90.47%92.50%92.48%96.25%96.25%96.40%96.07%95.94%
No. of Shareholders 1,20,8741,13,9421,17,0291,19,0261,35,1451,28,8501,31,8431,52,2961,54,2721,51,5061,48,6851,46,498

Shareholding Pattern Chart

No. of Shareholders

Evexia Lifecare Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.001.001.002.0010.00
Basic EPS (Rs.) 0.010.020.010.030.21
Diluted EPS (Rs.) 0.010.020.010.030.21
Cash EPS (Rs.) 0.010.020.010.030.24
Book Value[Excl.RevalReserv]/Share (Rs.) 2.451.731.252.3711.72
Book Value[Incl.RevalReserv]/Share (Rs.) 2.451.831.362.6012.86
Revenue From Operations / Share (Rs.) 0.580.791.052.4417.22
PBDIT / Share (Rs.) 0.020.040.030.080.35
PBIT / Share (Rs.) 0.010.030.030.070.31
PBT / Share (Rs.) 0.010.020.020.070.31
Net Profit / Share (Rs.) 0.000.010.010.020.20
NP After MI And SOA / Share (Rs.) 0.000.010.010.020.20
PBDIT Margin (%) 3.815.043.543.282.04
PBIT Margin (%) 2.284.302.973.011.81
PBT Margin (%) 1.303.422.192.881.80
Net Profit Margin (%) 0.842.440.951.141.20
NP After MI And SOA Margin (%) 0.842.440.951.141.20
Return on Networth / Equity (%) 0.201.120.791.171.76
Return on Capital Employeed (%) 0.300.280.252.362.12
Return On Assets (%) 0.100.150.070.670.89
Long Term Debt / Equity (X) 0.815.538.340.000.01
Total Debt / Equity (X) 0.835.618.450.070.10
Asset Turnover Ratio (%) 0.120.060.140.530.27
Current Ratio (X) 1.492.231.862.672.10
Quick Ratio (X) 1.462.211.822.632.04
Inventory Turnover Ratio (X) 0.030.700.620.412.17
Interest Coverage Ratio (X) 3.885.764.5624.67182.81
Interest Coverage Ratio (Post Tax) (X) 1.863.802.239.56108.78
Enterprise Value (Cr.) 877.51858.85812.50182.67916.31
EV / Net Operating Revenue (X) 7.9415.2611.682.428.59
EV / EBITDA (X) 207.97302.64329.8773.54421.22
MarketCap / Net Operating Revenue (X) 4.433.081.562.368.52
Price / BV (X) 1.071.421.302.4312.53
Price / Net Operating Revenue (X) 4.433.081.562.368.52
EarningsYield 0.000.010.010.000.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Evexia Lifecare Ltd. is a Public Limited Listed company incorporated on 23/11/1990 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L23100GJ1990PLC014692 and registration number is 014692. Currently company belongs to the Industry of Edible Oils & Solvent Extraction. Company's Total Operating Revenue is Rs. 83.89 Cr. and Equity Capital is Rs. 187.73 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Edible Oils & Solvent ExtractionTundav Anjesar Road, Village Tundav, Ta. Savli, Vadodra Gujarat 391775Contact not found
Management
NamePosition Held
Mr. Jayesh R ThakkarChairman & Managing Director
Mr. Hasmukh D ThakkarNon Exe.Non Ind.Director
Ms. Payal GajjarInd. Non-Executive Director
Mr. Mohammadraza MakraniInd. Non-Executive Director
Mr. Kartik B MistryInd. Non-Executive Director
Mr. Parth PatelInd. Non-Executive Director

FAQ

What is the intrinsic value of Evexia Lifecare Ltd and is it undervalued?

As of 18 April 2026, Evexia Lifecare Ltd's intrinsic value is ₹1.16, which is 127.45% higher than the current market price of ₹0.51, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (0.32 %), book value (₹3.02), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Evexia Lifecare Ltd?

Evexia Lifecare Ltd is trading at ₹0.51 as of 18 April 2026, with a FY2026-2027 high of ₹2.99 and low of ₹0.51. The stock is currently near its 52-week low. Market cap stands at ₹95.7 Cr..

How does Evexia Lifecare Ltd's P/E ratio compare to its industry?

Evexia Lifecare Ltd has a P/E ratio of 59.8, which is below the industry average of 263.21. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Evexia Lifecare Ltd financially healthy?

Key indicators for Evexia Lifecare Ltd: ROCE of 0.30 % is on the lower side compared to the industry average of 14.31%; ROE of 0.32 % is below ideal levels (industry average: 12.90%). Dividend yield is 0.00 %.

Is Evexia Lifecare Ltd profitable and how is the profit trend?

Evexia Lifecare Ltd reported a net profit of ₹1 Cr in Mar 2025 on revenue of ₹110 Cr. Compared to ₹1 Cr in Mar 2022, the net profit shows an improving trend.

Does Evexia Lifecare Ltd pay dividends?

Evexia Lifecare Ltd has a dividend yield of 0.00 % at the current price of ₹0.51. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Evexia Lifecare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports